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SUMMARY 
 
FRONT END INNOVATION  
AN ACTION-ORIENTED CASE STUDY  
OF FACTORS SUPPORTING FRONT END INNOVATION 
 
BY  
 
ANNABETH AAGAARD 
AALBORG UNIVERSITY 
H. LUNDBECK A/S 
 
Ideas are the foundation for innovation. Continuous innovation therefore requires a targeted 
focus and support of the organisation’s front end innovation (FEI). According to several 
authors, e.g. Reinertsen (1999), Dahl & Moreau (2002), Steven & Burly (2003), Boeddrich 
(2004) and Williams et al. (2007) an organisation benefits substantially by optimising and 
improving front end innovation actively and may thereby enhance the chances of developing 
innovations. Pharmaceutical innovation is unique, as it opposed to most other industries’ 
product development is science-driven and not customer-driven. In addition, the 
pharmaceutical front end of innovation, as represented by research, lasts up to five years and 
the entire R&D process constitutes a period of 10-12 years, which is furthermore highly 
regulated by the external authority, The American Food and Drug Administration (FDA). 
 
The research aim of this thesis has been: to contribute to the field of front end innovation by 
studying the factors supporting front end of innovation in theory, in practice and in action in a 
pharmaceutical company, H. Lundbeck A/S. The theoretical foundation is cross-paradigmatic 
and the following contributions were found in the literature study: 1) various innovation 
success factors are critical in supporting innovation, 2) the literature generally does not 
distinguish between factors supporting FEI and NPD, 3) the literature does not differentiate 
between trades and industries in relation to these factors, and 4) the choice between 
incremental and radical innovation affects the way to facilitate FEI. The academic contribution 
consists among others of a theoretical model, “The idea and innovation management house”, 
that explains, which factors are critical in supporting pharmaceutical FEI and in what order the 
factors should be prioritised. 
 
This study is one of the first action oriented studies of how to support pharmaceutical FEI. The 
empirical contributions and findings of the thesis underline that: 1) supporting FEI in practice 
in the pharmaceutical industry requires the promotion of specific factors, 2) the different 
organisational levels, seniority levels and geographies (headquarter/subsidiary) of the 
employee groups affect, which factors are the most important to support in practice, 3) the FEI 
process among the pharmaceutical companies are practically identical, and customers are not 
utilised directly in the pharmaceutical FEI, 4) Differences in national cultures influence the role 
of individuals and teams in FEI, 5) the level of structure and flexibility in the way FEI is carried 
out influence the level of exploration and radical innovation, 6) FEI can be improved in practice 
through mapping and implementation of targeted activities enhancing the identified factors 
and eliminating barriers of FEI, and 7) the leadership abilities and communication skills of the 
heads of departments determine the success and effects of implementing the targeted 
development activities. The practical contribution of the thesis is a guideline of how to support 
FEI in practice with recommendations of how to identify, implement and continuously support 
FEI through targeted innovation development activities and innovation action plans.  
